Schedule Update - effective 1 February 2009 (text extract)

This is the text extract for Schedule Update - effective 1 February 2009, browse documents here.

Pharmaceutical Management Agency Level 9, Cigna House, 40 Mercer Street, PO Box 10-254, Wellington 6143, New Zealand Phone: 64 4 460 4990 - Fax: 64 4 460 4995 - www.pharmac.govt.nz Freephone Information line (9am-5pm weekdays) 0800 66 00 50

Pharmaceutical Management Agency

Update

New Zealand Pharmaceutical Schedule

Effective 1 February 2009 Cumulative for January and February 2009. Section H cumulative for December 2008 and January, February 2009.

While care has been taken in compiling this Update, Pharmaceutical Management Agency takes no responsibility for any errors or omissions and shall not be liable to any person for any damages or loss arising out of reliance by that person for any purpose on any of the contents of this Update. Errors and omissions brought to the attention of Pharmaceutical Management Agency will be corrected if necessary by an erratum or otherwise in the next edition of the Update.

Contents

Summary of PHARMAC decisions effective 1 February 2009 ......................... 3 Section E PSO changes .................................................................................. 4 Named Specialist for antiretrovirals............................................................... 5 Liquid antibiotics - wastage rule change ....................................................... 6 Arimidex - removal of Special Authority ........................................................ 6 Diltiazem Hydrochloride changes .................................................................. 7 Tender News .................................................................................................. 8 Looking Forward ........................................................................................... 8 Sole Subsidised Supply products cumulative to February 2009 ..................... 9 New Listings ................................................................................................ 18 Changes to Restrictions ............................................................................... 19 Changes to Subsidy and Manufacturer’s Price............................................. 20 Changes to Description ............................................................................... 24 Changes to General Rules............................................................................ 24 Changes to Sole Subsidised Supply ............................................................. 24 Delisted Items ............................................................................................. 25 Items to be Delisted .................................................................................... 26 Section H changes to Part II ........................................................................ 29 Section H changes to Part IV ....................................................................... 31 Index ........................................................................................................... 32

Summary of PharmaC decisions

effeCtIve 1 feBrUarY 2009 New listings (page 18) • Condoms (Durex Extra Safe) 56 mm extra strength • Condoms (Durex Select Flavours) 56 mm • Mebendazole (Vermox) tab – temporary listing of new pack size, 4 tabs • Tranylcypromine sulphate (Parnate S29) tab 10 mg – new listing with Section 29 criteria Changes to restrictions (page 19) • Anastrozole (Arimidex) tab 1 mg – removal of Special Authority criteria Decreased subsidy (page 20) • Amlodipine (Calvasc) tab 5mg and 10 mg • Cetirizine hydrochloride (Razene) tab 10 mg • Cetirizine hydrochloride (Allerid C) oral liquid 1 mg per ml Increased subsidy (page 20) • Trimipramine maleate (Tripress) cap 25 mg and 50 mg

4 Pharmaceutical Schedule - Update News

Section E PSO changes

PHARMAC received requests from a number of pharmacists to add more detail to Section E Part I, Practitioner’s and Wholesale Supply Orders, so that health professionals do not need to refer back to Section B for the relevant information. Many health professionals view the items listed in Section E Part I as fully funded and not requiring any special prescribing requirements. This is not correct for some of the medicines listed. By adding the fully subsidised symbol “√” beside all pharmaceuticals where a fully subsidised brand is currently subsidised, this immediately makes it obvious which products do not incur a manufacturer’s surcharge. Some pharmaceuticals listed in Section E Part I are only eligible for a subsidy if certain prescribing restrictions are followed. These have not previously been printed in Section E Part I of the Pharmaceutical Schedule. They are fully explained in Section B but there has not been any cross-reference. By adding these prescribing restrictions, and a reference where required back to the listing in Section B, it easily clarifies which restrictions relate to the prescribing of a pharmaceutical on a PSO or WSO. These changes were made in response to feedback from subscribers and we are always open to such suggestions.

Pharmaceutical Schedule - Update News

Named Specialists for antiretrovirals

Below is a list of currently approved named Specialists that the Ministry of Heath has approved to prescribe HIV antiretroviral agents in New Zealand. Auckland Dr Rod Ellis-Pegler Dr Rick Franklin Dr David Holland Dr Joan Ingram Prof. Diana Lennon Dr Sally Roberts Dr Simon Rowley Dr Mark Thomas Dr Leslie Voss Dr Liz Wilson Dr Simon Briggs Dr Nicky Perkins Dr Stephen Ritchie Dr Mitzi Nisbet Dr Rupert Handy Palmerston North Dr Anne Robertson Wellington Dr Tim Blackmore Dr Nigel Raymond Dr Richard Steele Nelson Dr Richard Everts Hamilton Dr Graeme Mills Dr Jane Morgan Christchurch Dr Stephen Chambers Dr Maud Meates-Dennis Dr Alan Pithie Dr Sarah Metcalf Tauranga Dr Katherine Grimwade Dunedin Dr Deborah Williams Napier Dr Richard Meech Dr Andrew Burns

6 Pharmaceutical Schedule - Update News

Liquid antibiotics – wastage rule change

Currently, when a pharmacist dispenses a part pack of a reconstituted antibiotic oral liquid to which a diluent has been added at the time of dispensing; they will only be reimbursed for the quantity prescribed unless they satisfy the funder that the balance was wasted. The Pharmacy Procedures Manual states that additional payment for the wastage is dependent on the pharmacist claiming for the balance and stating that no further prescriptions in which the balance of the prescription could have been used were dispensed on the day of dispensing or the following two days. The general rules of the Pharmaceutical Schedule have been amended to include a provision for pharmacists to claim for wastage at the time of dispensing of oral reconstituted antibiotic liquids without the need to wait for two days. Note: for the purposes of audit and compliance it is an act of fraud to claim wastage and then use the wastage amount for any subsequent prescription. An initial proposal was to amend the listing of oral liquid antibiotics so that they would be paid as Original Packs. While feedback on the this proposal was unanimously in support of the change for antibiotic liquids to be paid as Original Packs, it was highlighted that such a change could cause discrepancies between what was prescribed or ordered by a practitioner and what was dispensed and claimed for at the time of dispensing. An amendment to claim for wastage at the time of dispensing seemed more appropriate. This change has been made with consultation from pharmacists, the Pharmacy Guild, The Pharmaceutical Society, Ministry of Health Sector Services and software vendors. PHARMAC considers this change as reducing an unnecessary administrative and stock control burden for pharmacists. PHARMAC would like to thank those parties that provided feedback on the proposal and remain open to similar changes in the future. The new rule is set out on page 24 of this update.

Arimidex – removal of Special Authority

A Special Authority restriction has applied to the Arimidex brand of anastrozole for full subsidy ($240 per 30) for women with early breast cancer who are intolerant of tamoxifen, or where tamoxifen is contraindicated. In the absence of Special Authority approval, a part subsidy ($146.46 per 30) applied. AstraZeneca has notified PHARMAC that it is reducing the price of its Arimidex brand of anastrozole to the level of the base subsidy ($146.46 per pack of 30). This means that the Special Authority for alternative subsidy is no longer required, as patients will now receive a full subsidy regardless of Special Authority status. In summary, as of 1 February 2009 there will be 2 brands of anastrozole 1 mg tablets available, both without Special Authority: • DP-Anastrozole, fully subsidised by endorsement for patients with hormone receptor positive advanced breast cancer (ex manufacturer price $29.50, exclusive of GST) • Arimidex, fully subsidised for all patients (ex manufacturer price $146.46, exclusive of GST)

Pharmaceutical Schedule - Update News

Diltiazem Hydrochloride changes

A letter was recently issued providing details of upcoming changes to the listing of diltiazem hydrochloride in the Pharmaceutical Schedule. A summary of the changes is provided below. Due to concerns around prescribing and dispensing errors for diltiazem hydrochloride, the following preparations will be delisted from the Pharmaceutical Schedule from 1 June 2009: • Dilzem SR 90 mg and 120 mg (twice daily) sustained release capsules • Dilzem LA 180 mg and 240 mg long-acting tablets The delisting of Dilzem SR (sustained release) and Dilzem LA (long-acting) will require current patients to be switched to another presentation. We suggest the following: Currently taking Dilzem SR 90 mg capsule (twice daily) Dilzem SR 120 mg capsule (twice daily) Dilzem LA 180 mg tablet (once daily) Dilzem LA 240 mg tablet (once daily) Suggested new presentation Cardizem CD 180 mg capsule (once daily) Cardizem CD 240 mg capsule (once daily) Cardizem CD 180 mg capsule (once daily) Cardizem CD 240 mg capsule (once daily)

Titration to a higher or lower dose may be necessary and should be initiated as clinically warranted

For patients taking Dilzem SR 90 mg or 120 mg once daily (even if it is not the recommended dosing regimen as the blood levels are not maintained above the minimum therapeutic level for 24 hours), we suggest the following: Currently taking Dilzem SR 90 mg capsule (once daily) Dilzem SR 120 mg capsule (once daily) Suggested new presentation Cardizem CD 120 mg capsule (once daily) Cardizem CD 120 mg capsule (once daily)

Those patients may be more likely to experience a change in effect therefore they should be monitored for adverse effects following the change.

For further information please call the Freephone Information Line (between 9am and 4pm weekdays) on 0800 66 00 50 or visit www.pharmac.govt.nz

tender News

Sole Subsidised Supply changes – effective 1 March 2009

Chemical Name Cefazolin soidum Flucloxacillin Presentation; Pack size Inj 500 mg Inj 1 g Inj 250 mg; 10 pack Inj 500 mg; 10 pack Inj 1 g; 10 pack Sole Subsidised Supply brand (and supplier) Hospira (Hospira) Flucloxin (Douglas)

Looking forward

This section is designed to alert both pharmacists and prescribers to possible future changes. It may assist pharmacists to manage stock levels and keep prescribers up-to-date with proposals to change the Pharmaceutical Schedule. Possible decisions for implementation 1 march 2009 • Acitretin (Neotigason) cap 10 mg and 25 mg – removal of Specialist Prescription restriction and the application of Special Authority criteria • Isotretinoin (Isotane) cap 10 mg and 20 mg – removal of Specialist Prescription restriction and the application of Special Authority criteria • Pantoprazole (Pantocid) inj 40 mg – new listing

Sole Subsidised Supply Products – cumulative to February 2009

Generic Name

Acetazolamide Aciclovir Alprazolam

Presentation

Tab 250 mg; 100 tab Tab dispersible 200 mg Tab dispersible 400 mg Tab 250 µg Tab 500 µg Tab 1 mg Inj 10 mg per ml, 1 ml Cap 100 mg Cap 250 mg & 500 mg Grans for oral liq 125 mg per 5 ml Grans for oral liq 250 mg per 5 ml Tab 100 mg Tab dispersible 300 mg Tab 100 mg Tab 50 mg & 100 mg Eye drops 1%; 15 ml OP Inj 600 µg, 1 ml Inj 1200 µg, 1 ml Tab 500 mg Metered aqueous nasal spray 50 µg Metered aqueous nasal spray 100 µg Inj 1 mega u; 10 inj Scalp app 0.1% Tab 200 mg; 90 tab Tab 50 mg Tab 5 mg Eye drops 0.2% Inj 0.5%, 4 ml Inj 0.5%, 8% glucose, 4 ml Lotion BP Crm, aqueous, BP Inj 100 iu per ml, 1 ml; 5 inj Cap 0.25 µg & 0.5 µg Tab eff 1 g; 30 tab Inj 50 mg Tab 12.5 mg, 25 mg & 50 mg Cap 250 mg Grans for oral liq 125 mg per 5 ml

Brand Name Expiry Date*

Diamox Lovir Lovir Arrow-Alprazolam Arrow-Alprazolam Arrow-Alprazolam Mayne Symmetrel Apo-Amoxi Ranbaxy Amoxicillin Ranbaxy Amoxicillin Apo-Ascorbic Acid Ethics Aspirin Ethics Aspirin EC Loten Atropt AstraZeneca AstraZeneca Arrow-Azithromycin Alanase Alanase Sandoz Beta Scalp Fibalip Bicalox Lax-Tab AFT Marcain Isobaric Marcain Heavy ABM ABM Miacalcic Calcitriol-AFT Calsource Calcium Folinate Ebewe Apo-Captopril Ranbaxy Cefaclor Ranbaxy Cefaclor 2011 2009 2010

Apomorphine hydrochloride Amantadine hydrochloride Amoxycillin

2009 2011 2010 2009 2009 2010 2009 2011 2009 2009 2009 2011 2009 2011 2011 2010 2011 2010 2009 2011 2009 2011 2011 2010 2010

Ascorbic acid Aspirin Atenolol Atropine sulphate

Azithromycin Beclomethasone dipropionate Benzylpenicillin sodium (Penicillin G) Betamethasone valerate Bezafibrate Bicalutamide Bisacodyl Brimonidine tartrate Bupivicaine hydrochloride Calamine Calcitonin Calcitriol Calcium Calcium folinate Captopril Cefaclor monohydrate

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated. 9

Sole Subsidised Supply Products – cumulative to February 2009

Generic Name

Cefuroxime sodium Cetomacrogol Chloramphenicol Chlorhexidine gluconate

Presentation

Inj 750 mg & 1.5 g Crm BP Eye drops 0.5% Eye oint 1% Soln 4% Handrub 1% with ethanol 70% Mouthwash 0.2% Tab 25 mg Tab 250 mg Grans for oral liq 125 mg per 5 ml Crm 0.05% Tab 500 µg; 100 tab Tab 2 mg; 100 tab Crm 1% Vaginal crm 1% with applicator(s) Tab 15 mg, 30 mg & 60 mg Tab 500 µg Sach 5 g Inj 150 mg Powder for soln for oral use Tab 50 mg Tab 50 mg Tab 50 mg Cap 25 mg & 50 mg Inj 500 mg Nasal spray 10 mcg per dose Inj 4 mg per ml, 1 ml Inj 4 mg per ml, 2 ml Tab 5 mg Inj 50%, 10 ml Oral soln with electrolytes

Brand Name Expiry Date*

Zinacef PSM Chlorsig Chlorsig Orion Orion Orion Hygroton Klamycin Klacid Dermol Paxam Paxam Clomazol Clomazol PSM Colgout Colestid Colistin-Link Enerlyte Nausicalm Cycloblastin Siterone Dantrium Mayne Desmopressin-PH&T Mayne PSM Biomed Pedialyte – Plain Pedialyte – Bubblegum Pedialyte – Fruit Voltaren Ophtha Voltaren Voltaren Voltaren Voltaren Voltaren Apo-Diclo Apo-Diclo SR 2011 2010 2009 2011 2009 2009 2010 2009 2011 2011 2010 2010 2010 2010 2010 2010 2009 2010 2009 2009 2010 2011 2009 2010 2011 2010

Chlorthalidone Clarithromycin Clobetasol propionate Clonazepam Clotrimazole Codeine phosphate Colchicine Colestipol hydrochloride Colistin sulphomethate Compound electrolytes Cyclizine hydrochloride Cyclophosphamide Cyproterone acetate Dantrolene sodium Desferrioxamine mesylate Desmopressin Dexamethasone sodium phosphate Dexamphetamine sulphate Dextrose Dextrose with electrolytes

Diclofenac sodium

Eye drops 1 mg per ml Inj 25 mg per ml, 3 ml Suppos 12.5 mg Suppos 25 mg Suppos 50 mg Suppos 100 mg Tab EC 25 mg & 50 mg Tab long-acting 75 mg & 100 mg

2011

2009

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated. 10

Sole Subsidised Supply Products – cumulative to February 2009

Generic Name

Didanosine (DDI) Dipyridamole Doxazosin mesylate Emulsifying ointment Enalapril Ergometrine maleate Ergotamine tartrate with caffeine Erythromycin ethyl succinate

Presentation

Cap 125 mg, 200 mg, 250 mg & 400 mg Tab long-acting 150 mg Tab 2 mg & 4 mg Oint BP Tab 5 mg, 10 mg & 20 mg Inj 500 µg per ml, 1 ml Tab 1 mg with caffeine 100 mg Grans for oral liq 200 mg per 5 ml; 100 ml Grans for oral liq 400 mg per 5 ml; 100 ml Tab 10 µg Tab 35 µg with norethisterone 500 µg Tab 35 µg with norethisterone 1 mg Tab 35 µg with norethisterone 1 mg and 7 inert tab Cap 50 mg & 100 mg Oral liq 150 mg per 5 ml Tab 5 mg; 30 tab Cap 250 mg & 500 mg Grans for oral liq 125 mg per 5 ml Grans for oral liq 250 mg per 5 ml Cap 50 mg Cap 150 mg Cap 200 mg Inj 50 mg Tab 10 mg Oint 950 µg, with fluocortolone pivalate 920 µg, and cinchocaine hydrochloride 5 mg per g Suppos 630 µg, with fluocortolone pivalate 610 µg, and cinchocaine hydrochloride 1 mg Eye drops 0.1% Cap 20 mg Tab disp 20 mg, scored Tab 0.8 mg & 5 mg Crm 2% & Oint 2%

Brand Name Expiry Date*

Videx EC Pytazen SR Apo-Doxazosin AFT m-Enalapril Mayne Cafergot E-Mycin E-Mycin New Zealand Medical and Scientific Brevinor 21 Brevinor 1/21 Brevinor 1/28 Vepesid Ferodan Fintral Staphlex AFT AFT Pacific Pacific Pacific Fludara Fludara Ultraproct Ultraproct 2009 2010 2011 2009 2009 2010 2009 2011 2010 2011 2009 2009 2009 2011

Ethinyloestradiol Ethinyloestradiol with norethisterone

Etoposide Ferrous sulphate Finasteride Flucloxacillin sodium

Fluconazole

2011

Fludarabine phosphate Fluocortolone caproate with fluocortolone pivalate and cinchocaine

2011 2010

Fluorometholone Fluoxetine hydrochloride Folic Acid Fusidic acid

Flucon Fluox Fluox Apo-Folic Acid Foban

2009 2010 2009 2010

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated. 11

Sole Subsidised Supply Products – cumulative to February 2009

Generic Name

Gentamicin sulphate Gliclazide Glipizide Glyceryl trinitrate

Presentation

Inj 40 mg per ml, 2 ml Tab 80 mg Tab 5 mg Oral pump spray 400 µg per dose TDDS 5 mg TDDS 10 mg Oral liq 2 mg per ml Tab 500 µg, 1.5 mg & 5 mg Inj 5 mg per ml, 1 ml Inj 10 iu per ml, 5 ml Crm 1% Tab 5 mg & 20 mg Rectal foam 10%, CFC-Free Scalp lotn 0.1% Lotn 1% with wool fat hydrous 3% and mineral oil Inj 20 mg, 1 ml Tab 20 mg Oral liq 100 mg per 5 ml, 200 ml Tab 10 mg & 25 mg Tab 2.5 mg Aqueous nasal spray, 0.03% Nebuliser soln, 250 µg per ml, 1 ml Nebuliser soln, 250 µg per ml, 2 ml Inj 50 mg per ml, 2 ml Tab long-acting 60 mg Cap 10 mg Cap 20 mg Cap 100 mg Shampoo 2%, 100 ml OP Oral liq 10 g per 15 ml Eye drops 0.25% & 0.5% Cap 50 mg with benserazide 12.5 mg Tab dispersible 50 mg with benserazide 12.5 mg Cap 100 mg with benserazide 25 mg Cap long-acting 100 mg with benserazide 25 mg Cap 200 mg with benserazide 50 mg

Brand Name Expiry Date*

Pfizer Apo-Gliclazide Minidiab Nitrolingual pumpspray Nitroderm TTS 5 Nitroderm TTS 10 Serenace Serenace Serenace AstraZeneca PSM Douglas Colifoam Locoid DP Lotn HC Buscopan Gastrosoothe Fenpaed Tofranil Napamide Apo-Ipravent Ipratripium Steri-Neb Ipratripium Steri-Neb Ferrum H Duride Isotane 10 Isotane 20 Sporanox Sebizole Duphalac Betagan Madopar 62.5 Madopar Dispersible Madopar 125 Madopar HBS Madopar 250 2009 2011 2011 2011

Haloperidol

2010 2009 2009 2011 2009 2009 2010 2011 2011 2010 2009 2009 2010

Heparinised saline Hydrocortisone Hydrocortisone acetate Hydrcortisone butyrate Hydrocortisone with wool fat and mineral oil Hysocine N-butylbromide Ibuprofen Imipramine hydrochloride Indapamide Ipratropium bromide

Iron polymaltose Isosorbide mononitrate Isotretinoin Itraconazole Ketoconazole Lactulose Levobunolol Levodopa with benserazide

2011 2009 2009 2010 2011 2010 2010 2009

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated. 12

Sole Subsidised Supply Products – cumulative to February 2009

Generic Name

Lignocaine hydrochloride

Presentation

Inj 0.5%, 5 ml Inj 1%, 5 ml Inj 1%, 20 ml Crm 2.5% with prilocaine 2.5%; 30 g OP Crm 2.5% with prilocaine 2.5%; 5 g Tab 5 mg, 10 mg & 20 mg Tab 2 mg Tab 10 mg Oral liq 1 mg per ml

Brand Name Expiry Date*

Xylocaine Xylocaine Xylocaine EMLA EMLA Arrow-Lisinopril Nodia Loraclear Hayfever Relief Lorapaed Ativan Mayne Derbac M A-Lices Ludiomil Colofac Provera Pentasa Arrow-Metformin Methatabs AFT Methotrexate Ebewe Methotrexate Ebewe Methoblastin Prodopa Prodopa Prodopa Rubifen SR Rubifen Rubifen Medrol Advantan Depo-Medrol Depo-Medrol with Lidocaine Solu-Medrol Solu-Medrol Solu-Medrol 2009 2010 2010 2010

Lignocaine with prilocaine

2010

Lisinopril Loperamide hydrochloride Loratadine

Lorazepam Magnesium sulphate Malathion Maldison Maprotiline hydrochloride Mebeverine hydrochloride Medroxyprogesterone acetate Mesalazine Metformin hydrochloride Methadone hydrochloride Methotrexate

Tab 1 mg & 2.5 mg Inj 49.3% Liq 0.5% Shampoo 1% Tab 25 mg & 75 mg Tab 135 mg; 90 tab Tab 2.5 mg, 5 mg, 10 mg, 100 mg & 200 mg Enema 1 g per 100 ml Tab 500 mg & 850 mg Tab 5 mg Powder 1 g Inj 100 mg per ml, 10 ml Inj 100 mg per ml, 50 ml Tab 2.5 mg & 10 mg Tab 125 mg; 100 tab Tab 250 mg; 100 tab Tab 500 mg; 100 tab Tab long-acting 20 mg Tab 5 mg & 20 mg Tab 10 mg Tab 4 mg & 100 mg Crm 0.1% and oint 0.1% Inj 40 mg per ml, 1 ml Inj 40 mg per ml with lignocaine 1 ml Inj 40 mg per ml, 1 ml Inj 62.5 mg per ml, 1 ml Inj 500 mg & 1 g

2009 2009 2010 2010 2009 2011 2010 2009 2009 2010 2009 2011 2009 2011

Methyldopa

Methylphenidate hydrochloride

2009

Methylprednisolone Methylprednisolone aceponate Methylprednisolone acetate Methylprednisolone acetate with lignocaine Methylprednisolone sodium succinate

2009 2009 2011 2011 2009

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated. 13

Sole Subsidised Supply Products – cumulative to February 2009

Generic Name

Metoclopramide hydrochloride Metoprolol tartrate Metyrapone Miconazole nitrate Midodrine Misoprostol Moclobemide Morphine hydrochloride

Presentation

Inj 5 mg per ml, 2 ml Tab long-acting 200 mg Cap 250 mg Crm 2% Tab 2.5 mg & 5 mg Tab 200 µg Tab 150 mg & 300 mg Oral liq 1 mg per ml Oral liq 2 mg per ml Oral liq 5 mg per ml Oral liq 10 mg per ml Inj 10 mg per ml, 1 ml Inj 30 mg per ml, 1 ml Inj 5 mg per ml, 1 ml Inj 15 mg per ml, 1 ml Cap long-acting 10 mg, 30 mg, 60 mg, 100 mg & 200 mg Tab immediate release 10 mg & 20 mg Inj 80 mg per ml, 1.5 ml & 5 ml Tab 40 mg & 80 mg Tab 50 mg Tab 250 mg Tab 500 mg Tab 275 mg Inj 2.5 mg per ml, 1 ml Oral suspension 10 mg per ml Tab 50 mg & 500 mg Tab long-acting 20 mg Tab 5 mg Tab 350 µg Tab 10 mg; 100 tab Tab 25 mg; 250 tab Oral liq 100,000 u per ml, 24 ml OP Cap 500,000 u Tab 500,000 u Vaginal crm 100,000 u per 5 g with applicators Tab 4 mg & 8 mg Tab disp 4 mg & 8 mg

Brand Name Expiry Date*

Pfizer Slow-Lopresor Metopirone Multichem Gutron Cytotec Apo-Moclobemide RA-Morph RA-Morph RA-Morph RA-Morph Mayne Mayne Mayne Mayne m-Eslon Sevredol Mayne Apo-Nadolol ReVia Noflam 250 Noflam 500 Sonaflam AstraZeneca Viramune Suspension Apo-Nicotinic Acid Nyefax Retard Primolut N Noriday 28 Norpress Norpress Nilstat Nilstat Nilstat Nilstat Zofran Zofran Zydis 2009 2010 2010 2009 2010 2010 2009 2009 2009 2011 2009 2011 2011 2010 2009 2010 2011 2009 2009 2011 2009 2009 2009 2009

Morphine sulphate

2011 2009

Morphine tartrate Nadolol Naltrexone hydrochloride Naproxen Naproxen sodium Neostigmine Nevirapine Nicotinic acid Nifedipine Norethisterone Nortriptyline hydrochloride Nystatin

Ondansetron

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated. 14

Sole Subsidised Supply Products – cumulative to February 2009

Generic Name

Oxybutynin Oxycodone hydrochloride Oxytocin

Presentation

Tab 5 mg Oral liq 5 mg per 5 ml Inj 10 mg per ml, 1 ml and 2 ml Oral liq 5 mg per 5 ml Inj 5 iu per ml, 1 ml Inj 10 iu per ml, 1 ml Inj 5 iu with ergometrine maleate 500 µg per ml, 1 ml Inj 3 mg per ml, 5 ml Inj 3 mg per ml, 10 ml Inj 6 mg per ml, 10 ml Tab 20 mg Tab 40 mg

Brand Name Expiry Date*

Apo-Oxybutynin Apo-Oxybutynin OxyNorm OxyNorm Syntocinon Syntocinon Syntometrine Pamisol Pamisol Pamisol Dr Reddy’s Pantoprazole Dr Reddy’s Pantoprazole Paracare Junior Paracare Double Strength Lacri-Lube Loxamine Permax Permax Pexsig AFT AFT Cilicaine VK Cilicaine VK Prefrin Coloxyl Vistil Vistil Forte Span-K Apo-Prazo Apo-Prednisone Apo-Prednisone Apo-Prednisone Apo-Prednisone MDS Quick Card Cilicaine Allersoothe Apo-Pyridoxine 2010 2010 2009

Pamidronate disodium

2011

Pantoprazole

2010

Paracetamol

Oral liq 120 mg per 5 ml Oral liq 250 mg per 5 ml Eye oint with soft white paraffin Tab 20 mg Tab 0.25 mg Tab 1 mg Tab 100 mg Grans for oral liq 125 mg per 5 ml Grans for oral liq 250 mg per 5 ml Cap potassium salt 250 mg Cap potassium salt 500 mg Eye drops 0.12% Oral drops 10%, 30 ml OP Eye drops 1.4% Eye drops 3% Tab long-acting 600 mg Tab 1 mg, 2 mg & 5 mg Tab 1 mg; 500 tab Tab 2.5 mg; 500 tab Tab 5 mg; 500 tab Tab 20 mg; 500 tab Cassette Inj 1.5 mega u; 5 inj Tab 10 mg Tab 25 mg Tab 50 mg

2011

Paraffin liquid with soft white paraffin Paroxetine hydrochloride Pergolide Perhexiline maleate Phenoxymethylpenicillin (Penicillin V)

2010 2010 2011 2009 2010

Phenylephrine hydrochloride Poloxamer Polyvinyl alcohol Potassium chloride Prazosin hydrochloride Prednisone

2010 2011 2011 2009 2010 2011

Pregnancy tests - HCG urine Procaine penicillin Promethazine Pyridoxine hydrochloride

2009 2011 2011 2009

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated. 15

Sole Subsidised Supply Products – cumulative to February 2009

Generic Name

Quinapril Quinapril with hydroclorothiazide

Presentation

Tab 5 mg; 10 mg & 20 mg Tab 10 mg with hydroclorothiazide 12.5 mg Tab 20 mg with hydroclorothiazide 12.5 mg Tab 200 mg Tab 300 mg Oral liq 150 mg per 10 ml Cap 150 mg Tab 150 mg & 300 mg Nebuliser soln 1 mg per ml, 2.5 ml Nebuliser soln 2 mg per ml, 2.5 ml Oral liq 2 mg per 5 ml Nebuliser soln, 2.5 mg with ipratropium bromide 0.5 mg Tab 5 mg Inj 0.9%, 5 ml & 10 ml Grans eff 4 g sachets Nasal spray 4% Tab 500 mg Tab EC 500 mg Liq Soln 2.3%; 500 ml and 1,000 ml

Brand Name Expiry Date*

Accupril Accuretic 10 Accuretic 20 Q 200 Q 300 Peptisoothe Mycobutin Arrow-Roxithromycin Asthalin Asthalin Salapin Duolin Apo-Selegiline AstraZeneca Ural Rex Salazopyrin Salazopyrin EN Midwest Pinetarsol 2009 2010 2010 2009 2009 2010 2009 2009 2009 2010 2009 2009 2010 2011 2011 2011

Quinine sulphate Ranitidine hydrochloride Rifabutin Roxithromycin Salbutamol

Salbutamol with ipratropium bromide Selegiline hydrochloride Sodium chloride Sodium citro-tartrate Sodium cromoglycate Sulphasalazine Syrup (pharmaceutical grade) Tar with triethanolamine lauryl sulphate and fluorescein sodium Temazepam Terbinafine Testosterone cypionate Tetracosactrin Timolol maleate

Tab 10 mg; 25 tab Tab 250 mg Inj long-acting 100 mg per ml, 10 ml Inj 250 mcg Inj 1 mg per ml, 1 ml Eye drops 0.25% Eye drops 0.5% Tab 10 mg Tab 50 mg Crm 0.02%; 100 g OP Oint 0.02%; 100 g OP Inj 40 mg per ml, 1 ml; 5 inj 0.1% in Dental Paste USP Ear drops 1 mg with nystatin 100,000 u, neomycin sulphate 2.5 mg and gramicidin 250 mcg per g

Normison Apo-Terbinafine Depo-Testosterone Synacthen Synacthen Depot Apo-Timop Apo-Timop Apo-Timol Apo-Thiamine Aristocort Aristocort Kenacort-A40 Oracort Kenacomb

2011 2011 2011 2011 2011 2009 2009 2011 2011 2009

Thiamine hydrochloride Triamcinolone acetonide

Triamcinolone acetonide with gramicidin, neomycin and nystatin

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated. 16

Sole Subsidised Supply Products – cumulative to February 2009

Generic Name

Trimethoprim Ursodeoxycholic acid Vancomycin hydrochloride Vincristine sulphate Vitamins Vitamin B complex Water Zinc and castor oil Zinc sulphate Zopiclone February changes in bold type.

Presentation

Tab 300 mg; 50 tab Cap 300 mg Inj 50 mg per ml, 10 ml; 1 inj Inj 1 mg per ml, 1 ml Inj 1 mg per ml, 2 ml Tab (BPC cap strength) Tab, strong, BPC Purified for injection 20 ml Ointment BP Cap 220 mg; 100 cap Tab 7.5 mg

Brand Name Expiry Date*

TMP Actigall Pacific Mayne Mayne Healtheries Apo-B-Complex Multichem PSM Zincaps Apo-Zopiclone 2011 2011 2011 2009 2009 2009 2009 2011 2011 2011

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated. 17

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

New Listings

Effective 1 February 2009

73 CONDOMS ❋ 56 mm extra strength - Up to 144 dev available on a PSO ........ 13.36 ❋ 56 mm - Up to 144 dev available on a PSO .............................. 13.36 MEBENDAZOLE – Only on a prescription Tab 100 mg .............................................................................. 2.53 (7.43) TRANYLCYPROMINE SULPHATE Tab 10 mg .............................................................................. 22.94 144 144 ✔ Durex Extra Safe ✔ Durex Select Flavours

4 Vermox 50 ✔ Parnate S29

114

Effective 1 January 2009

109 123 184 ALLOPURINOL ❋ Tab 100 mg .............................................................................. 5.44 ❋ Tab 300 mg .............................................................................. 4.03 (Note: Progout tabs 100 mg and 300 mg to be delisted 1 June 2009) CLOZAPINE – Hospital pharmacy [HP4] Oral liq 50 mg per ml ............................................................... 34.65 250 100 ✔ Apo-Allopurinol ✔ Apo-Allopurinol

100 ml

✔ Clopine

GLUTEN FREE PASTA – Special Authority see SA0722 – Hospital pharmacy [HP3] Italian long style spaghetti .......................................................... 2.00 220 g (3.11)

Orgran

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Restrictions

Effective 1 February 2009

143 ANASTROZOLE Tab 1 mg – Higher subsidy of $240.00 per 30 with Special Authority see SA0942 ........................................................ 146.46 30 (240.00) Arimidex ➽ SA0942 Special Authority for Alternate Subsidy Initial application - New Patients - only from a relevant specialist. Approvals valid for 5 years for applications meeting the following criteria: All of the following: 1 Patient is a postmenopausal woman; and 2 Patient has hormone receptor positive early breast cancer; and 3 Either: 3.1 The patient has a very clear history of intolerance to tamoxifen; or 3.2 The use of tamoxifen is contraindicated due to a history of thromboembolic disease. Initial application – Patient has had a Special Authority approval for anastrozole prior to 1 December 2008 – only from a relevant specialist. Approval valid without further renewal unless notified where the treatment remains appropriate and the patient is benefiting from treatment. Renewal - only from a relevant specialist. Approvals valid without further renewal unless notified where the treatment remains appropriate and the patient is benefiting from treatment. Note: If the patient had an approval for anastrozole prior to 1 December 2008 the applicant is required to submit a fresh initial application in the first instance, not a renewal application. Please phone Ministry of Health Sector Services on 0800 243 666 for clarification if needed.

Effective 1 January 2009

EXTEMPORANEOUSLY COMPOUNDED PRODUCTS AND GALENICALS Standard Formulae 167 MAGNESIUM HYDROXIDE MIXTURE Magnesium hydroxide paste .................................................. 275 g Methylhydroxybenzoate ............................................................. 1.5 g Water .................................................................................... 770 ml (Not subsidised as a laxative)

▲

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Subsidy and Manufacturer’s Price

Effective 1 February 2009

27 ZINC OXIDE ( price) Oint zinc oxide with balsam peru ................................................ 4.50 (6.67) Suppos zinc oxide with balsam peru .......................................... 4.47 (6.49) AMLODIPINE ( subsidy) ❋ Tab 5 mg .................................................................................. 2.20 ❋ Tab 10 mg ................................................................................ 3.54 50 g OP Anusol 12 Anusol 30 30 ✔ Calvasc ✔ Calvasc

TRIAMCINOLONE ACETONIDE WITH GRAMICIDIN, NEOMYCIN AND NYSTATIN ( price) Crm 1 mg with nystatin 100,000 u, neomycin sulphate 2.5 mg and gramicidin 250 µg per g – Only on a prescription............ 3.49 15 g OP (6.60) AQUEOUS ( price) ❋ Crm........................................................................................... 2.28 UREA ( price) ❋ Crm 10% ................................................................................... 2.52 (3.07) TRIMIPRAMINE MALEATE ( subsidy and price) Cap 25 mg ................................................................................ 6.20 Cap 50 mg .............................................................................. 11.20 ANASTROZOLE ( price) Tab 1 mg .............................................................................. 146.46 CETIRIZINE HYDROCHLORIDE ( subsidy) ❋ Tab 10 mg ................................................................................ 1.99 (3.32) ❋ Oral liq 1 mg per ml ................................................................... 1.75 (2.75) 500 g 100 g OP

Viaderm KC ✔ Multichem

68 68

Nutraplus 100 100 30 90 Razene 100 ml OP Allerid C ✔ Tripress ✔ Tripress ✔ Arimidex

114

143 150

Effective 1 January 2009

29 OMEPRAZOLE ( subsidy and  price) ❋ Cap 10 mg ................................................................................ 2.14 (8.43) ❋ Cap 20 mg ................................................................................ 3.05 (9.00) ❋ Cap 40 mg ................................................................................ 3.59 (11.25) 30 Losec 30 Losec 30 Losec

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Subsidy and Manufacturer’s Price - effective 1 January 2009 (continued)

58 NIFEDIPINE ( subsidy and price) ❋ Tab long-acting 30 mg ............................................................ 10.70 ❋ Tab long-acting 60 mg ........................................................... 15.35 68 AQUEOUS CREAM ( subsidy) ❋ Crm........................................................................................... 2.28 (2.37) CLOTRIMAZOLE ( subsidy) ❋ Vaginal crm 2% with applicators ................................................ 3.44 (3.99) AMOXYCILLIN ( subsidy) Drops 125 mg per 1.25 ml ........................................................ 2.67 (7.25) Inj 250 mg ................................................................................ 6.21 (6.32) Inj 500 mg ................................................................................ 7.12 (7.32) Inj 1 g ..................................................................................... 10.8 (11.00) 91 CIPROFLOXACIN ( subsidy) Tab 250 mg – Up to 5 tab available on a PSO ............................ 3.13 Tab 500 mg – Up to 5 tab available on a PSO ............................ 4.57 (8.31) Tab 750 mg – Up to 5 tab available on a PSO ............................ 7.04 PYRIDOSTIGMINE BROMIDE ( subsidy) ▲ Tab 60 mg .............................................................................. 40.08 PARACETAMOL ( price) Tab 500 mg - Up to 30 available on a PSO ................................. 1.38 (14.67) 137.81 (1,467.00) CITALOPRAM HYDROBROMIDE ( subsidy) ❋ Tab 20 mg ................................................................................ 1.26 (3.50) 119 120 METOCLOPRAMIDE HYDROCHLORIDE WITH PARACETAMOL ( subsidy) Tab 5 mg with paracetamol 500 mg........................................... 6.77 60 30 30 ✔ Arrow-Nifedipine XR ✔ Adefin XL ✔ Arrow-Nifedipine XR ✔ Adefin XL

500 g Multichem 25 g OP Clotrimaderm 2% 20 ml OP Amoxil Paediatric Drops 5 Ibiamox 5 Ibiamox 5 Ibiamox 28 28 28 100 150 Panadol 15,000 Panadol 28 ✔ Cipflox Cipflox ✔ Cipflox

104 110

✔ Mestinon

114

✔ Arrow-Citalopram ✔ Citalopram-Rex Celapram

✔ Paramax

HYOSCINE (SCOPOLAMINE) – Special Authority see SA0727 – Hospital Pharmacy [HP3] ( subsidy) Patches 1.5 mg ....................................................................... 11.95 2 ✔ Scopoderm TTS

▲

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Subsidy and Manufacturer’s Price - effective 1 January 2009 (continued)

123 CLOZAPINE – Hospital pharmacy [HP4] ( subsidy) Tab 25 mg .............................................................................. 13.37 13.37 26.74 Tab 50 mg .............................................................................. 17.33 34.65 Tab 100 mg ............................................................................ 34.65 34.65 69.30 Tab 200 mg ............................................................................ 55.45 110.90 50 50 100 50 100 50 50 100 50 100 ✔ Clopine ✔ Clozaril ✔ Clopine ✔ Clopine ✔ Clopine ✔ Clozaril ✔ Clopine ✔ Clopine ✔ Clopine ✔ Clopine

136

OXALIPLATIN – PCT only – Specialist – Special Authority see SA0900 ( subsidy and price) Inj 50 mg .............................................................................. 200.00 1 ✔ Eloxatin Inj 100 mg ............................................................................ 400.00 1 ✔ Eloxatin Inj 1 mg for ECP ........................................................................ 4.36 1 mg ✔ Baxter OCTREOTIDE (SOMATOSTATIN ANALOGUE) - Special Authority see SA0563 – Hospital pharmacy [HP3] ( subsidy) Inj 50 µg per ml,1 ml .............................................................. 25.65 (43.50) Inj 100 µg per ml, 1 ml ........................................................... 48.50 (81.00) Inj 500 µg per ml, 1 ml .......................................................... 175.00 (399.00) HYPROMELLOSE ( subsidy) ❋ Eye drops 0.5% ........................................................................ 2.00

146

5 Sandostatin 5 Sandostatin 5 Sandostatin

161 184

15 ml OP

✔ Methopt

GLUTEN FREE PASTA – Special Authority see SA0722 – Hospital Pharmacy [HP3] ( price) Buckwheat Spirals ..................................................................... 2.00 250 g OP (3.11) Orgran Corn and Spinach Rigattini......................................................... 2.00 250 g OP (2.92) Orgran Corn and Vegetable Shells ......................................................... 2.00 250 g OP (2.92) Orgran Corn and Vegetable Spirals ........................................................ 2.00 250 g OP (2.92) Orgran Garlic and Parsley Shells ........................................................... 2.00 250 g OP (2.92) Orgran Rice and Corn Garden Herb Pasta .............................................. 2.00 250 g OP (2.92) Orgran Rice and Corn Lasagne Sheets .................................................. 2.00 200 g OP (3.82) Orgran Rice and Corn Macaroni ............................................................ 2.00 250 g OP (2.92) Orgran Rice and Corn Penne ................................................................. 2.00 250 g OP (2.92) Orgran Rice and Maize Pasta Spirals ..................................................... 2.00 250 g OP (2.92) Orgran Rice and Millet Spirals ............................................................... 2.00 250 g OP (3.11) Orgran continued...

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Subsidy and Manufacturer’s Price - effective 1 January 2009 (continued)

continued... Rice and corn spaghetti noodles ................................................ 2.00 (2.92) Vegetable and Rice Spirals......................................................... 2.00 (2.92) 375 g OP Orgran 250 g OP Orgran

▲

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Description

Effective 1 January 2009

38 CALCIUM Tab eff 1 g (elemental) ............................................................. 6.54 30 ✔ Calsource

Changes to General Rules

Effective 1 February 2009

21 3.4 Original packs, and certain Antibiotics 3.4.2 If a Community Pharmaceutical is the liquid form of an antibiotic to which a diluent must be added by the Contractor at the time of dispensing and it is prescribed or ordered by a Practitioner in an amount that does not coincide with the amount contained in one or more of standard packs of the Community Pharmaceutical, Subsidy will only be made paid for the amount prescribed or ordered by the Practitioner in accordance with either clause 3.1 or clause 3.3 of the Schedule, and for the unless the Contractor satisfies the Funder that he or she has not been able to dispense the balance of any the pack or packs from which the Community Pharmaceutical has been dispensed. At the time of dispensing the Contractor must keep a record of the quantity discarded. In such cases all of that pack or those packs is eligible for subsidy. To ensure wastage is reduced, the Contractor should reduce the amount dispensed to make it equal to the quantity contained in a whole pack where: (i) the difference the amount dispensed and the amount prescribed by the Practitioner is less than 10% (eg; if a prescription is for 105 mls then a 100ml pack would be dispensed); and (ii) in the reasonable opinion of the Contractor the difference would not affect the efficacy of the course of treatment prescribed by the Practitioner. Note: For the purposes of audit and compliance it is an act of fraud to claim for a whole pack (which includes a wastage amount) and then dispense the wastage amount for a subsequent prescription.

Changes to Sole Subsidised Supply

Effective 1 February 2009

For the list of new Sole Subsidised Supply products effective 1 February 2009 refer to the bold entries in the cumulative Sole Subsidised Supply table pages 9-17.

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Delisted Items

Effective 1 February 2009

160 POLYVINYL ALCOHOL ❋ Eye drops 1.4 % ........................................................................ 2.68 ❋ Eye drops 3 % ........................................................................... 3.75 15 ml OP 15 ml OP ✔ Liquifilm Tears ✔ Liquifilm Forte

Effective 1 January 2009

29 114 184 OMEPRAZOLE ❋ Cap 10 mg ................................................................................ 2.14 (5.95) ❋ Cap 20 mg ................................................................................ 3.05 (5.95) ❋ Cap 40 mg ................................................................................ 3.59 (8.84) NORTRIPTYLINE HYDROCHLORIDE Tab 25 mg .............................................................................. 34.90 30 Omezol 30 Omezol 30 Omezol 500

✔ Norpress

GLUTEN FREE PASTA – Special Authority see SA0722 – Hospital Pharmacy [HP3] Garlic and Parsley spirals .......................................................... 2.00 250 g (2.63)

Orgran

▲

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Items to be Delisted

Effective 1 March 2009

59 91 VERAPAMIL HYDROCHLORIDE ❋ Tab 40 mg ................................................................................ 4.75 FLUCLOXACILLIN SODIUM Inj 250 mg ............................................................................... 4.50 (4.66) Inj 500 mg ................................................................................ 5.20 (5.45) Inj 1 g ....................................................................................... 7.00 (7.54) 100 5 Flucloxin 5 Flucloxin 5 Flucloxin ✔ Verpamil

Effective 1 April 2009

90 AMOXYCILLIN Drops 125 mg per 1.25 ml ........................................................ 2.67 (7.25) Inj 250 mg ............................................................................... 6.21 (6.32) Inj 500 mg ................................................................................ 7.12 (7.23) Inj 1 g – Up to 5 inj available ona PSO...................................... 10.81 (11.00) 114 CITALOPRAM HYDROBROMIDE ( subsidy) ❋ Tab 20 mg ................................................................................ 1.26 (3.50) 146 20 ml OP Amoxil Paediatric Drops 5 Ibiamox 5 Ibiamox 5 Ibiamox 28

✔ Arrow-Citalopram ✔ Citalopram-Rex Celapram

OCTREOTIDE (SOMATOSTATIN ANALOGUE) – Special Authority see SA0563 – Hospital Pharmacy [HP3] Inj 50 µg per ml, 1 ml .............................................................. 25.65 5 (43.50) Sandostatin Inj 100 µg per ml, 1 ml ............................................................ 48.50 5 (81.00) Sandostatin Inj 500 µg per ml, 1 ml .......................................................... 175.00 5 (399.00) Sandostatin PHENYL FREE PASTA – Special Authority see SA0733 – Hospital pharmacy [HP3] Macaroni ................................................................................. 10.65 500 g OP (11.91)

186

Loprofin

Effective 1 May 2009

53 81 DOXAZOSIN MESYLATE ❋ Tab 2 mg ................................................................................. 4.81 Note – the 500 tablet pack listed 1 November 2008 OESTRADIOL VALERATE – See prescribing guideline ❋ Tab 2 mg ................................................................................. 4.12 100 ✔ Apo-Doxazosin

✔ Progynova

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Effective 1 June 2009

53 DOXAZOSIN MESYLATE ❋ Tab 4 mg .................................................................................. 6.37 Note – the 500 tablet pack listed 1 December 2008 ALLOPURINOL Tab 100 mg ............................................................................ 11.45 Tab 300 mg ............................................................................ 21.20 CARBAMAZEPINE ❋ Tab 200 mg ........................................................................ 29.06 Note – the 100 tablet pack size listed 1 December 2008 100 ✔ Apo-Doxazosin

109

500 500 200

✔ Progout ✔ Progout ✔ Tegretol

115

Effective 1 July 2009

48 WATER 1) on a prescription or Practitioner’s Supply order only when on the same form as an injection listed in the Pharmaceutical Schedule requiring a solvent or diluent; or 2) on a bulk supply order; or 3) When used in the extemporaneous compounding of eye drops Purified for inj 2 ml – Up to 5 ink available on a PSO ................ 21.90 50 ✔ Baxter CROTAMITON a) Only on a prescription b) Not in combination Lotn 10% .................................................................................. 7.56 (7.70) FLUOROURACIL SODIUM Inj 500 mg per ml, 20 ml – PCT only – Specialist ..................... 55.60

50 ml Eurax 10 ✔ Mayne

137 177

PAEDIATRIC ORAL FEED 1.5KCAL/ML –Special Authority see SA0986 – Hospital pharmacy [HP3] Liquid (chocolate) ..................................................................... 1.27 200 ml OP ✔ Resource Just for Kids Liquid (vanilla)........................................................................... 1.27 200 ml OP ✔ Resource Just for Kids GLUTEN FREE PASTA – Special Authority see SA0722 – Hospital pharmacy [HP3] Corn and Parsley fettucine ......................................................... 2.00 250 g OP (2.63)

184

Orgran

Effective 1 August 2009

45 48 88 MENADIONE SODIUM BISULPHITE ❋ Tab 10 mg ................................................................................ 4.75 HEPARINISED SALINE ❋ Inj 100 iu per ml, 2 ml ............................................................... 8.30 MEBENDAZOLE Tab 100 mg .............................................................................. 3.79 (7.59) 100 10 6 Vermox ✔ K-Thrombin ✔ Hospira S29

▲

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Items to be Delisted - effective 1 August 2009 (continued)

174 ORAL FEED 1KCAL/ML –Special Authority see SA0594 – Hospital Pharmacy [HP3] Liquid (chocolate) ..................................................................... 1.78 237 ml OP ✔ Resource Diabetic

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply

Contracted Pharmaceutical Description

Brand

Price ($) (ex man. excl. GST)

Per

DV Limit

DV Limit DV applies Pharmaceutical from

Section H changes to Part II

Effective 1 February 2009

AMOXYCILLIN WITH CLAVULANIC ACID ( price) Inj 600 mg, 500 mg with 100 mg clavulanic acid ..............Augmentin Inj 1.2 g, 1000 mg with 200 mg clavulanic acid ..............Augmentin FENTANYL ( price) Inj 50 µg per ml, 2 ml .....................Hospira Inj 50 µg per ml, 10 ml ...................Hospira ZOPICLONE Tab 7.5 mg.....................................Apo-Zopiclone Note: DV date amended from Jan-09 to Feb-09

28.24 31.60 6.10 15.65 21.02

10 10 5 5 500 1% Feb-09 Imovane

Effective 1 January 2009

ALLOPURINOL (new listing and HSS) Tab 100 mg ...................................Apo-Allopurinol Tab 300 mg....................................Apo-Allopurinol 5.44 4.03 250 100 1% 1% Mar-09 Mar-09 Allohexal Allorin Progout Allohexal Allorin Progout

(Note: Progout 100 mg and 300 mg to be delisted 1 March 2009) CLOZAPINE (new listing) Oral liq 50 mg per ml .....................Clopine CLOZAPINE ( price) Tab 25 mg......................................Clozaril Clopine Clopine Tab 50 mg......................................Clopine Clopine Tab 100 mg....................................Clozaril Clopine Clopine Tab 200 mg....................................Clopine Clopine HYOSCINE (SCOPOLAMINE) (new listing) Patches 1.5 mg .............................Scopoderm TTS HYPROMELLOSE (new listing and HSS) Eye drops 0.5% ..............................Methopt 45.60 13.37 26.74 17.33 34.65 34.65 69.30 55.45 110.90 11.95 2.00 100 ml 50 100 50 100 50 100 50 100 2 15 ml 1% Mar-09 (B)

Products with Hospital Supply Status (HSS) are in bold.

(B) – Subject only to part (b) of the definition of “DV Pharmaceutical”

Contracted Pharmaceutical Description

Brand

Price ($) (ex man. excl. GST)

Per

DV Limit

DV Limit DV applies Pharmaceutical from

Section H changes to Part II – effective 1 January 2009 (continued)

NIFEDIPINE ( price) Tab long-acting 30 mg....................Arrow-Nifedipine XR10.70 Adefin XL Tab long-acting 60 mg....................Arrow-Nifedipine XR15.35 Adefin XL OMEPRAZOLE (new listing) Inf 40 mg ......................................Dr Reddy’s Omeprazole 38.65 30 30

OMEPRAZOLE ( price) Cap 10 mg .....................................Losec 8.43 30 Cap 20 mg .....................................Losec 9.00 30 Cap 40 mg .....................................Losec 11.25 30 (Note: Losec 10 mg, 20 mg and 40 mg to be delisted 1 May 2009) OXALIPLATIN ( price) Inj 50 mg........................................Eloxatin Inj 100 mg......................................Eloxatin 200.00 400.00 1 1

Effective 1 December 2008

ADRENALINE (new listing) Inj 1,000, 1 ml ................................Aspen-Adrenaline AMISULPRIDE (new listing) Tab 100 mg....................................Solian Tab 200 mg....................................Solian Tab 400 mg....................................Solian Oral liquid 100 mg per ml ...............Solian AMLODIPINE (new listing) Tab 5 mg........................................Apo-Amlodipine 4.98 22.52 97.03 185.44 55.44 7.33 5 30 60 60 60 ml 100 100 1% 1% Feb-09 Feb-09 Calvasc Norvasc Calvasc Norvasc

Tab 10 mg......................................Apo-Amlodipine 11.79 ANASTROZOLE-DP (new listing) Tab 1 mg........................................DP-Anastrozole CEFAZOLIN SODIUM (delisting) Inj 500 mg......................................m-Cefazolin Inj 1 g.............................................m-Cefazolin

29.50 13.60 18.60

30 10 10

Products with Hospital Supply Status (HSS) are in bold.

(B) – Subject only to part (b) of the definition of “DV Pharmaceutical”

Contracted Pharmaceutical Description

Brand

Price ($) (ex man. excl. GST)

Per

DV Limit

DV Limit DV applies Pharmaceutical from

Section H changes to Part II – effective 1 December 2008 (continued)

CETIRIZINE HYDROCHLORIDE (new listing) Tab 10 mg......................................Zetop 2.21 100 1% Feb-09 Apo-Cetirizine Allerid-C Cetirizine Histaclear Razene Allerid-C Zyrtec

Oral Liquid 1 mg per 1 ml ..............Cetirizine-AFT Note – Allerid-C to be delisted 1 Feb 2009 DILTIAZEM HYDROCHLORIDE (new listing) Tab 30 mg......................................Dilzem Tab 60 mg......................................Dilzem Cap long-acting 120 mg .................Cardizem CD Cap long-acting 180 mg .................Cardizem CD Cap long-acting 240 mg .................Cardizem CD

3.50

200 ml

Feb-09

4.50 8.50 4.72 7.08 9.44

100 100 30 30 30

5% 5% 5% 5% 5% 1%

Jun-09 Jun-09 Jun-09 Jun-09 Jun-09 Jan-09

(B) (B) (B) Dilzem LA Dilzem LA Dosan

DOXAZOSIN MESYLATE (new listing) Tab 4 mg........................................Apo-Doxazosin 30.26 500 Note – Apo-Doxazosin tab 4 mg 100 tablet pack size to be delisted 1 Feb 2009 FLUOROURACIL SODIUM (new listing) Crm 5% ..........................................Efudix POTASSIUM CHLORIDE (delisting) Inj 75 mg per ml, 10 ml ..................AstraZeneca Inj 150 mg per ml, 10 ml ................AstraZeneca 26.49 26.00 26.00 20 g 50 50

Section H changes to Part IV

Effective 1 December 2008

SPECIAL FOOD SUPPLEMENT Liquid, 237 ml Impact Advanced Recovery Vanilla and Chocolate Three packs of 237 mls per days for 5 to 7 days prior to major gastrointestinal or head or neck surgery.

Products with Hospital Supply Status (HSS) are in bold.

(B) – Subject only to part (b) of the definition of “DV Pharmaceutical”

Index

Pharmaceuticals and brands A Adefin XL ..................................................... 21, 30 Adrenaline.......................................................... 30 Allerid C ............................................................. 20 Allopurinol.............................................. 18, 27, 29 Amisulpride........................................................ 30 Amlodipine................................................... 20, 30 Amoxil Paediatric Drops ............................... 21, 26 Amoxycillin .................................................. 21, 26 Amoxycillin with clavulanic acid ......................... 29 Anastrozole .................................................. 19, 20 Anastrozole-DP .................................................. 30 Anusol ............................................................... 20 Apo-Allopurinol ............................................ 18, 29 Apo-Amlodipine ................................................. 30 Apo-Doxazosin....................................... 26, 27, 31 Apo-Zopiclone.................................................... 29 Aqueous ............................................................ 20 Aqueous cream .................................................. 21 Arimidex ...................................................... 19, 20 Arrow-Citalopram ......................................... 21, 26 Arrow-Nifedipine XR ..................................... 21, 30 Aspen-Adrenaline ............................................... 30 Augmentin ......................................................... 29 C Calcium ............................................................. 24 Calsource .......................................................... 24 Calvasc.............................................................. 20 Carbamazepine .................................................. 27 Cardizem CD ...................................................... 31 Cefazolin sodium ............................................... 30 Celapram ..................................................... 21, 26 Cetirizine-AFT..................................................... 31 Cetirizine hydrochloride ................................ 20, 31 Cipflox ............................................................... 21 Ciprofloxacin ...................................................... 21 Citalopram hydrobromide ............................. 21, 26 Citalopram-Rex ............................................ 21, 26 Clopine .................................................. 18, 22, 29 Clotrimaderm 2% ............................................... 21 Clotrimazole ....................................................... 21 Clozapine ............................................... 18, 22, 29 Clozaril ........................................................ 22, 29 Condoms ........................................................... 18 Crotamiton ......................................................... 27 D Diltiazem hydrochloride ...................................... 31 Dilzem ............................................................... 31 Doxazosin mesylate ............................... 26, 27, 31 DP-Anastrozole .................................................. 30 Dr Reddy’s Omeprazole...................................... 30 Durex Extra Safe................................................. 18 Durex Select Flavours ......................................... 18 E Efudix ................................................................ 31 Eloxatin ........................................................ 22, 30 Eurax ................................................................. 27 F Fentanyl ............................................................. 29 Flucloxacillin sodium .......................................... 26 Flucloxin ............................................................ 26 Fluorouracil sodium...................................... 27, 31 G Gluten free pasta .............................. 18, 22, 25, 27 H Heparinised saline .............................................. 27 Hyoscine (scopolamine)............................... 21, 29 Hypromellose............................................... 22, 29 I Ibiamox........................................................ 21, 26 Impact Advanced Recovery Vanilla and Chocolate 31 K K-Thrombin........................................................ 27 L Liquifilm Forte .................................................... 25 Liquifilm Tears ................................................... 25 Loprofin ............................................................. 26 Losec .......................................................... 20, 30 M Magnesium hydroxide mixture ............................ 19 m-Cefazolin ....................................................... 30 Mebendazole................................................ 18, 27 Menadione sodium bisulphite ............................. 27 Mestinon............................................................ 21 Methopt ....................................................... 22, 29 Metoclopramide hydrochloride with paracetamol 21 N Nifedipine..................................................... 21, 30 Norpress ............................................................ 25 Nortriptyline hydrochloride.................................. 25 Nutraplus ........................................................... 20 O Octreotide (somatostatin analogue) .............. 22, 26 Oestradiol valerate.............................................. 26 Omeprazole............................................ 20, 25, 30 Omezol .............................................................. 25 Oral feed 1kcal/ml .............................................. 28 Orgran ....................................... 18, 22, 23, 25, 27 Oxaliplatin .................................................... 22, 30 P Paediatric oral feed 1.5kcal/ml............................ 27 Panadol ............................................................. 21 Paramax ............................................................ 21 Parnate .............................................................. 18

Index

Pharmaceuticals and brands Phenyl free pasta ............................................... 26 Polyvinyl alcohol ................................................ 25 Potassium chloride ............................................ 31 Progout.............................................................. 27 Progynova ......................................................... 26 Pyridostigmine bromide...................................... 21 R Razene .............................................................. 20 Resource Diabetic .............................................. 28 Resource Just for Kids ....................................... 27 S Sandostatin .................................................. 22, 26 Scopoderm TTS ........................................... 21, 29 Solian ................................................................ 30 Special food supplement .................................... 31 T Tegretol ............................................................. 27 Tranylcypromine sulphate .................................. 18 Triamcinolone acetonide with gramicidin, neomycin and nystatin ....................................................... 20 Trimipramine maleate ......................................... 20 Tripress ............................................................. 20 U Urea................................................................... 20 V Verapamil hydrochloride ..................................... 26 Vermox ........................................................ 18, 27 Verpamil ............................................................ 26 Viaderm KC........................................................ 20 W Water ................................................................. 27 Z Zetop ................................................................. 31 Zinc oxide .......................................................... 20 Zopiclone ........................................................... 29

Metadata

Title

Schedule Update - effective 1 February 2009

Abstract

Page 1

Note

This text has been extracted from the source PDF document.

Also available as plain text.

Please contact webmaster to discuss alternative format options.